4D Molecular Therapeutics, Inc. (FDMT) Targets Eye Diseases

4D Molecular Therapeutics, Inc. (FDMT) is a clinical-stage biopharmaceutical company focused on developing next-generation gene therapies. Using its proprietary AAV-based vector platform, the company designs targeted treatments for genetic eye diseases, rare conditions, and oncology. 4DMT’s growth is driven by advancing clinical trials, expanding its pipeline of precision therapies, and partnerships that support the development of breakthrough genetic medicines.

On the chart, a confirmation bar with rising volume highlights bullish strength. The price has entered the momentum zone by moving above the .236 Fibonacci level. A trailing stop can be set just below this Fibonacci line using the Fibonacci snap tool, helping traders secure profits while leaving room for further upside potential.